687 related articles for article (PubMed ID: 22135381)
1. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
[TBL] [Abstract][Full Text] [Related]
2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
3. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T;
Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288
[TBL] [Abstract][Full Text] [Related]
4. Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?
Akpınar EE; Hoşgün D; Akpınar S; Ateş C; Baha A; Gülensoy ES; Ogan N
J Bras Pneumol; 2019 Aug; 45(4):e20180417. PubMed ID: 31411279
[TBL] [Abstract][Full Text] [Related]
5. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides for early prediction of acute kidney injury in community-acquired pneumonia.
Nowak A; Breidthardt T; Dejung S; Christ-Crain M; Bingisser R; Drexler B; Meune C; Marono D; Mosimann T; Müller B; Müller C
Clin Chim Acta; 2013 Apr; 419():67-72. PubMed ID: 23415693
[TBL] [Abstract][Full Text] [Related]
7. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
8. Clinical Impact of N-Terminal Prohormone of Brain Natriuretic Peptide on Patients Hospitalized with Community-Acquired Pneumonia.
Seo H; Cha SI; Shin KM; Lim JK; Choi SH; Lee YH; Yoo SS; Lee SY; Lee J; Kim CH; Park JY
Am J Med Sci; 2020 Oct; 360(4):383-391. PubMed ID: 32690276
[TBL] [Abstract][Full Text] [Related]
9. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
Vazquez M; Jockers K; Christ-Crain M; Zimmerli W; Müller B; Schuetz P
Int J Cardiol; 2012 Apr; 156(1):16-23. PubMed ID: 21093937
[TBL] [Abstract][Full Text] [Related]
10. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia.
Christ-Crain M; Breidthardt T; Stolz D; Zobrist K; Bingisser R; Miedinger D; Leuppi J; Tamm M; Mueller B; Mueller C
J Intern Med; 2008 Aug; 264(2):166-76. PubMed ID: 18298480
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of plasma N-terminal pro B-type natriuretic peptide levels in pneumonia patients requiring intensive care unit admission.
Lin SC; Tsai YJ; Huang CT; Kuo YW; Ruan SY; Chuang YC; Yu CJ
Respirology; 2013 Aug; 18(6):933-41. PubMed ID: 23600467
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A;
Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562
[TBL] [Abstract][Full Text] [Related]
14. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
15. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL;
Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795
[TBL] [Abstract][Full Text] [Related]
16. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
Masiá M; Papassotiriou J; Morgenthaler NG; Hernández I; Shum C; Gutiérrez F
Clin Chem; 2007 Dec; 53(12):2193-201. PubMed ID: 17951293
[TBL] [Abstract][Full Text] [Related]
17. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults.
Chang CL; Mills GD; Karalus NC; Jennings LC; Laing R; Murdoch DR; Chambers ST; Vettise D; Tuffery CM; Hancox RJ
PLoS One; 2013; 8(5):e62612. PubMed ID: 23667500
[TBL] [Abstract][Full Text] [Related]
19. Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients.
Berdal JE; Stavem K; Omland T; Hall C; Smith-Erichssen N
Acta Anaesthesiol Scand; 2008 Oct; 52(9):1265-72. PubMed ID: 18823467
[TBL] [Abstract][Full Text] [Related]
20. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
